Wang C Y, Benson R C, Bryan G T
J Natl Cancer Inst. 1977 Apr;58(4):871-3. doi: 10.1093/jnci/58.4.871.
Urine samples from 12 humans receiving oral therapeutic doses of nitrofurantoin were mutagenic for Salmonella typhimurium strain TA 100 and nonmutagenic for strain TA 100-FR1. Mutagenic activity of the urine was not increased by treatment with beta-glucuronidase. Spot mutation assay of the chromatogram of urine revealed that the mutagenic activity of the urine was mainly due to unmetabolized nitrofurantoin.
12名接受口服治疗剂量呋喃妥因的人类受试者的尿液样本对鼠伤寒沙门氏菌TA 100菌株具有致突变性,而对TA 100 - FR1菌株无致突变性。用β-葡萄糖醛酸酶处理后,尿液的致突变活性并未增加。尿液色谱的斑点突变分析表明,尿液的致突变活性主要归因于未代谢的呋喃妥因。